June 30, 2020
AG 2020 - Résultat vote AGM 30 juin 2020
May 23, 2019
AG 2019 - Votes results
May 23, 2019
AG 2019 - Presentation
May 31, 2018
AG 2018 - Résultats des votes de l'Assemblée générale mixte 2018
May 17, 2018
AG 2018 - Presentation de l'Assemblée générale 2018
April 09, 2021
AG 2021 - Notice of information related to preparatory documents for the Ordinary and Extraordinary Shareholders’ Meeting of May 20, 2021
July 24, 2020
AG 2020 - CAC Rapport Comptes Consolidés 2019
June 30, 2020
AG 2020 - Descriptif du programme de rachat d'actions
June 12, 2020
AG 2020 - Brochure de convocation
June 09, 2020
AG 2020 - CAC Attestation Rémunération
April 09, 2021
AG 2021 - Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of May 20, 2021
June 12, 2020
AG 2020 - Avis de convocation
May 25, 2020
AG 2020 - Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of June 30, 2020
May 03, 2019
AG 2019 - Avis de convocation
April 15, 2019
2019 - Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of May 23, 2019

 

INFORMATION - General Shareholders Meeting 2021

The shareholders of bioMérieux (the “Company”) are hereby invited to attend the Ordinary and Extraordinary Shareholders’ Meeting to be held at 2:00 p.m. (CEST) on May 20, 2021 at 376 Chemin de l’Orme, Marcy l’Etoile (69280), France.

 

IMPORTANT – HEALTH SITUATION

In view of the ongoing health crisis, the Company may have to modify the conditions for participating in the Annual General Meeting of May 20, 2021. Thus, in the event that the conditions set out in Order no. 2020-321 of March 25, 2020 (as amended by Order no. 2020-1497 of December 2, 2020) and Decree No. 2020-418 of April 10, 2020 (as amended by Decree no. 2020-1614 of December 18, 2020), as extended by Decree no. 2021-255 of March 9, 2021, are still met and/or that health conditions so require, the Annual General Meeting may be held behind closed doors.

Consequently, shareholders are encouraged to regularly consult the Company’s website at www.biomerieux.com (Investors > Shareholder Area > General Shareholders’ Meeting), which may be updated to specify the definitive conditions for participating in the Annual General Meeting, depending on health and/or legal requirements.

Furthermore, in view of the circulation of COVID-19 and the government recommendations to avoid public gatherings, the Board of Directors urges the utmost caution and recommends that each shareholder opt to vote by post or by giving proxy to the Chairman rather than attending in person.

The Company has taken all measures to facilitate remote voting so that shareholders may also vote without physically attending the Annual General Meeting, either by using the designated postal voting form available on bioMérieux’s website at www.biomerieux.com (Investors > Shareholder Area > General Shareholders’ Meeting) or by logging on to the VOTACCESS secure voting platform.

Shareholders are asked to send all requests and documents to the following email address: investor.relations@biomerieux.com